Lexicon Pharmaceuticals
LXRX
#6581
Rank
C$1.20 B
Marketcap
C$2.70
Share price
4.67%
Change (1 day)
35.31%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2026 (TTM): -C$85.64 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are C$41.46 Million. In 2025 the company made an earning of -C$71.31 Million, an increase over its 2024 earnings that were of -C$0.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$85.64 Million20.09%
2025 -C$71.31 Million-74.88%
2024 -C$0.29 Billion13.15%
2023 -C$0.26 Billion73.74%
2022 -C$0.15 Billion16.16%
2021 -C$0.13 Billion49.82%
2020 -C$82.98 Million-147.19%
2019 C$0.17 B-203.42%
2018 -C$0.18 Billion-15.31%
2017 -C$0.21 Billion0.2%
2016 -C$0.21 Billion2920.7%
2015 -C$6.64 Million-95.33%
2014 -C$0.15 Billion-3.61%
2013 -C$0.15 Billion-5.52%
2012 -C$0.16 Billion-4.17%
2011 -C$0.17 Billion15.5%
2010 -C$0.15 Billion8.36%
2009 -C$0.14 Billion-4.81%
2008 -C$0.14 Billion28.79%
2007 -C$0.11 Billion35.71%
2006 -C$78.24 Million52.91%
2005 -C$51.17 Million-23.89%
2004 -C$67.22 Million-24.19%
2003 -C$88.67 Million-0.48%
2002 -C$89.09 Million44.12%
2001 -C$61.82 Million23.01%
2000 -C$50.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
C$10.81 B-12,595.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$1.64 B-1,998.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$7.31 B-8,552.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-C$0.72 Billion 727.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$0.34 B-499.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C$0.11 B-229.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-C$32.93 Million-61.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.21 B-343.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-C$23.41 Million-72.97%๐Ÿ‡บ๐Ÿ‡ธ USA